Document is current
Any future updates will be listed below
-
Authors
Bougas, Nicolas
Dabakuyo Yonli, Tienhan Sandrine
Assogba, Emerline
Haddy, Nadia
De Vathaire, Florent
Janah, Asmaa
Michel, Morgane
Bourmaud, Aurelie
Jeanningros, Hugo
Ursino, Moreno
Debailly, Renaud
Dumas, Agnes https://orcid.org/0000-0001-7948-6952
-
Funding
Funding for this research was provided by:
SIRIC CURAMUS
Institut National Du Cancer (INCA_15900)
- License Information
-
More Information
Article History
Received: 5 February 2025
Accepted: 7 May 2025
First Online: 4 June 2025
Declarations
:
: Not applicable.
: The study was approved by the Institutional Review Board of Inserm (IRB00003888, approval n. 21–815) and participants were informed and gave their consent as required by the French law. All data processing complied with the General Data Protection Regulation (GDPR) and the French law regulating the process of personal data in France.
: Dr S. Dabakuyo Yonli et Dr E. Assogba received funding from the “Pfizer Innovation France” for the Candy study. The other authors declare no competing interests.
